May 19, 2005 — The U.S. Food and Drug Administration (FDA) has approved infliximab injection to reduce the signs and symptoms of active psoriatic arthritis, a 10% solution of immune globulin G (IgG) ...
October 16, 2006 — The European Commission has approved pregabalin capsules for the treatment of central neuropathic pain associated with spinal cord injury, stroke, and multiple sclerosis; and ...
The efficacy and safety of Remsima (subcutaneous) compared with Remsima (intravenous) in people with Crohn's disease and ulcerative colitis was assessed in an unpublished open-label randomised, phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback